Specialists of the Center's HTA Department are attending the conference of the International Society for Pharmacoeconomics and Outcomes Research ISPOR Europe 2023: “Health Economics and Outcomes Research (HEOR) as a Link between Policy and Science” (“ISPOR Europe 2023: HEOR at the Nexus of Policy and Science”).
The main purpose of the business trip is to further build capacity for the implementation of HTA in Ukraine based on international experience.
The delegation included: Oresta Piniazhko, Director of the Department of HTA and Rational Pharmacotherapy, and specialists of the Division for Evaluation of the Cost-Effectiveness of Medical Technologies – Valeriia Serediuk and Marharyta Khmelovska.
During the first day of her participation, Oresta Piniazhko took part in a round table with representatives of more than 65 HTA competent authorities from 36 European countries. The main aim of the discussion was to build HTA capacity in Europe, to encourage the generation of high-quality evidence for better HTA assessments, and to strengthen engagement with stakeholders in the HTA process – clinicians, payers for medical technologies and medical services, and patients.
According to the conference schedule, the Center’s representatives will take part in plenary sessions and sessions, and will give two podium presentations and poster presentations. The participation of Oresta Piniazhko as a speaker during the session on disease-specific HTA reference models is planned.
The conference runs during November 12-15, 2023.
